Chronic Ankle Instability Diagnostic Tests Determining Underlying Deficits
Launched by UNIVERSITY HOSPITAL, LILLE · Jan 23, 2019
Trial Information
Current as of May 06, 2025
Terminated
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Case subject : at least one initial lateral ankle sprain more than 12 months before inclusion
- • Case subject : at least one residual symptom among (1) giving way, (2) sensation of instability, (3) recurrent ankle sprain. This item is confirmed by a score inferior than 24 on the Chronic Ankle Instability Tool (CAIT)
- • Case subject : Impact on activities of daily living and sport, confirmed by a score of less than 90% on the Foot and Ankle Ability Measure (FAAM) and less than 80% on FAAM-- - -- Control subject : matched by age and sex to case subjects
- Exclusion Criteria:
- • Surgery of one of the lower limbs less than 3 years ago
- • Presence of heavy pain (EVA \> 8) regardless of its origin
- • Acute lateral ankle sprain less than 4 months before inclusion
- • Neurological disorders of any kind
- • Medical treatment (drugs) interfering with muscle tone, balance and proprioception disorders
- • Pregnant or breastfeeding women
- • Body mass index \> 30
- • Bilateral chronic ankle instability
About University Hospital, Lille
University Hospital Lille is a leading academic medical institution dedicated to advancing healthcare through innovative clinical research and patient-centered care. As a prominent sponsor of clinical trials, the hospital leverages its extensive resources, multidisciplinary expertise, and state-of-the-art facilities to facilitate groundbreaking studies across various medical fields. Committed to enhancing therapeutic options and improving patient outcomes, University Hospital Lille collaborates with researchers, healthcare professionals, and industry partners to ensure rigorous scientific standards and ethical practices in all clinical trials.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Saint Omer, , France
Patients applied
Trial Officials
Alexandre Arnould, MD
Principal Investigator
University Hospital, Lille
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials